Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-06-04
2000-11-28
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435 11, 435366, 435402, 623 15, A01N 102, A61F 210, A61K 3839, C12N 508
Patent
active
061535931
ABSTRACT:
The use of laminin-5 to promote formation of basement membrane and to form skin equivalents and to improve grafting of keratinocyte sheets.
REFERENCES:
patent: 4485096 (1984-11-01), Bell
patent: 5352668 (1994-10-01), Burgeson et al.
patent: 5514364 (1996-05-01), Ildstad
patent: 5580960 (1996-12-01), Burgeson et al.
patent: 5660982 (1997-08-01), Tryggvason et al.
patent: 5770562 (1998-06-01), Burgeson et al.
patent: 6034068 (2000-03-01), Halberstadt
J. Invest. Dermatol. vol. 108, No. 4, pp. 549,585. Abstract Nos. 70 (Coberly et al) and 288 (Tsunenaga et al), Apr. 1997.
Adachi Eijiro
Amano Satoshi
Burgeson Robert E.
Nishiyama Toshio
Shioya Nobuyuji
Myers Louis
Russel Jeffrey E.
Shiseido Co. Ltd.
The General Hospital Corporation
University School of Medicine
LandOfFree
Laminin 5 and the formation of basement membrane structure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Laminin 5 and the formation of basement membrane structure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Laminin 5 and the formation of basement membrane structure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1725955